The Alliance for Regenerative Medicine’s cell and gene therapy ’Meeting on the Med’ (CGMED22) is coming to Perdigó’s home city of Barcelona from the 12th to the 14th of April 2022.
In this context, Perdigó is proud to unveil AdvaCTS: the concept of a cell therapy manufacturing system developed by Perdigó in collaboration with NIBRT (National Institute for Bioprocessing Research and Training).
Perdigó engineers and manufactures bespoke biopharmaceutical equipment. For more information on AdvaCTS, see our case study.
To meet with Perdigó CEO Arnau during the conference, get in touch with us. For details on this and upcoming editions of Cell & Gene Meeting on the Med, follow this link:
